Where Bayer-Monsanto’s $66 billion merger stands now – St. Louis Business Journal
|
Where Bayer-Monsanto's $66 billion merger stands now
St. Louis Business Journal … by Monsanto's licensing agreement with gene-editing technology such as Harvard and MIT's CRISPR-Cas9 and CRISPR–Cpf1. Monsanto Chief Technology Officer Robb Fraley told Reuters in September, before the announcement of the merger with Bayer, … |
